CAMBRIDGE, Mass., Oct. 20 /PRNewswire/ -- Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better understand large-scale biology, announced today that it has appointed Julian Ray, Ph.D. as vice president of Engineering. In his new role, Dr. Ray will be responsible for managing the continued evolution of the Genstruct technology platform, customer platforms and the company's IT functions.
"Julian's role is vital to the future of our company," said William Ladd, Ph.D., senior vice president, Technology Platform & Operations at Genstruct. "Our propriety computational modeling platform is used to define drug-induced efficacy and toxicity in our collaborations with pharmaceutical and biotech companies and enabled Genstruct to deliver actionable insights for these companies. By hiring Julian as a dedicated expert focused specifically on advancing our Causal Systems Modeling platform, we will be able to remain ahead of the technology curve."
"The capabilities of Genstruct's technology platform to mine large sets of literature and data, incorporate knowledge and test and validate models against experimental data is truly unique to the industry," said Dr. Ray. "I look at my new role as a great opportunity to take an already robust technology system and make further enhancements to solve the biological modeling challenges of life sciences companies."
Dr. Ray has more than 18 years of experience in designing, developing and deploying innovative solutions to challenging technology and information management systems problems. Prior to joining Genstruct, Dr. Ray was the chief technology officer (CTO) at auctionPAL, a venture-backed technology- enabled business-to-consumer services company. From 2004 to 2007, he was the co-founder and CTO for C2GLogistics, an Internet startup providing a suite of web-based services and mobile applications with a large customer base in the life sciences industry. In 1999, he co-founded and held the position of CTO/VP of Engineering for TransDecisions Inc., a software firm providing enterprise-class decision support software. Dr. Ray has also served as a senior software scientist at Intergraph Corporation and director of the Transportation Research Center at the University of Tennessee.
Dr. Ray has presented more than 30 technical papers at professional and academic conferences and authored a dozen peer-reviewed articles in academic publications and conference proceedings. He received his Ph.D. and M.S. degrees from the University of Tennessee and his B.S. from Reading University in the United Kingdom.
Founded in 2002, Genstruct is a systems biology company focused on elucidating the complexity of biology for the development of safe and effective therapeutics and molecular diagnostics. By developing Causal Network(TM) models for complex biological systems, Genstruct develops a deep molecular understanding of diseases and drug action, and designs mechanistic biomarkers and molecular diagnostics to facilitate drug development and personalized medicine. Genstruct's Consulting Services division engages in short-, mid- and long-term partnerships with top tier pharmaceutical and life sciences companies, to develop new therapeutics and mechanistic biomarkers in the areas of oncology, metabolic disorders, cardiovascular diseases and inflammation. Genstruct was awarded the Bio-IT World 2008 Best Practices Award in the Drug Discovery & Development category for its joint collaboration with Sirtris Pharmaceuticals (a GSK company). Genstruct is a privately held company based in Cambridge, Mass. For more information, please visit http://www.genstruct.com.
Genstruct and the Genstruct logo are registered trademarks and Causal
Network Model and Knowledge Assembly are trademarks of Genstruct, Inc. All
other trademarks or registered trademarks are properties of their
A & E Communications for Genstruct
|SOURCE Genstruct, Inc.|
Copyright©2008 PR Newswire.
All rights reserved